Mayflower Financial Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $401K | Sell |
3,613
-63
| -2% | -$6.99K | 0.06% | 268 |
|
|
2025
Q1 | $412K | Buy |
3,676
+249
| +7% | +$27.9K | 0.06% | 256 |
|
|
2024
Q4 | $317K | Buy |
+3,427
| New | +$317K | 0.05% | 287 |
|
|
2022
Q4 | – | Sell |
-4,767
| Closed | -$294K | – | 356 |
|
|
2022
Q3 | $294K | Buy |
4,767
+73
| +2% | +$4.5K | 0.05% | 253 |
|
|
2022
Q2 | $290K | Sell |
4,694
-58
| -1% | -$3.58K | 0.04% | 253 |
|
|
2022
Q1 | $283K | Sell |
4,752
-878
| -16% | -$52.3K | 0.04% | 283 |
|
|
2021
Q4 | $409K | Buy |
5,630
+74
| +1% | +$5.38K | 0.05% | 219 |
|
|
2021
Q3 | $372K | Sell |
5,556
-482
| -8% | -$32.3K | 0.05% | 228 |
|
|
2021
Q2 | $416K | Buy |
6,038
+3
| +0% | +$207 | 0.06% | 195 |
|
|
2021
Q1 | $390K | Sell |
6,035
-6
| -0.1% | -$388 | 0.06% | 191 |
|
|
2020
Q4 | $352K | Buy |
+6,041
| New | +$352K | 0.06% | 179 |
|